Lucaparib 300mg Tablet is a targeted therapy medication used in the treatment of certain types of cancer. Its active ingredient, Lucaparib, belongs to a class of drugs known as PARP (poly ADP-ribose polymerase) inhibitors. PARP enzymes play a crucial role in DNA repair within cells. In cancer cells, particularly those with specific genetic mutations like BRCA mutations, these repair mechanisms are already compromised. Lucaparib works by blocking the action of PARP enzymes, preventing cancer cells from repairing their damaged DNA. This leads to an accumulation of DNA damage, ultimately causing the cancer cells to die.
Lucaparib 300mg Tablet is indicated for the treatment of adult patients with deleterious or suspected deleterious germline or somatic BRCA-mutated (as determined by an FDA-approved test) advanced ovarian cancer, fallopian tube cancer, or primary peritoneal cancer who have been treated with two or more prior lines of chemotherapy. It is also used for the maintenance treatment of adult patients with advanced ovarian cancer, fallopian tube cancer, or primary peritoneal cancer, whose disease is a response to first-line or subsequent platinum-based chemotherapy.
The typical dosage is 600 mg (two 300 mg tablets) taken orally twice daily with or without food. It is crucial to take Lucaparib exactly as prescribed by your healthcare provider. Common side effects may include nausea, fatigue, anemia, elevated liver enzymes, and changes in blood cell counts. Serious side effects can occur, so it’s important to discuss any concerns with your doctor. Store Lucaparib 300mg Tablets at room temperature, away from moisture and heat.
